Form 4: GTCR Sells 8M Sotera Health Shares in Secondary Offering

GTCR entities disposed of 8 million shares of Sotera Health Co. common stock in an underwritten public secondary offering at $15.111 per share.

Summary

• GTCR Investment XI LLC and affiliated funds (GTCR XI Funds) sold a total of 8,000,000 shares of Sotera Health Company (SHC) Common Stock.
• The sale occurred on September 5, 2025, as part of an underwritten public secondary offering.
• The shares were sold at a price of $15.111 per share.
• Following the offering, the GTCR XI Funds beneficially own 41,215,301 shares of Common Stock.
• The transaction was made pursuant to a Rule 10b5-1(c) plan, indicating a pre-arranged sale.
• The GTCR entities, including GTCR Investment XI LLC, GTCR Fund XI/A LP, GTCR Fund XI/C LP, GTCR Co-Invest XI LP, and GTCR Partners XI/A&C LP, are identified as 10% owners and have director representation in Sotera Health Co.

Sentiment

Score: 5

Explanation: The sentiment is neutral. While a large insider sale can sometimes be viewed negatively, this was a pre-planned transaction by a private equity firm, which is a common part of their investment lifecycle. It does not necessarily reflect a negative outlook on the company's fundamentals, but rather a strategic divestment.

Positives

• The transaction provides liquidity for the selling GTCR entities, allowing them to realize value from their investment.
• The underwritten public secondary offering suggests market demand for Sotera Health shares at the specified price.

Negatives

• A significant sale by a major institutional shareholder and 10% owner could be perceived as a reduction in conviction or a signal of potential future selling pressure.
• The sale represents a substantial reduction in GTCR's ownership stake in Sotera Health Co.

Future Outlook

The filing does not provide specific forward-looking statements or guidance regarding Sotera Health Co.'s future performance or strategic direction. It primarily reports a past transaction by a significant shareholder.

Industry Context

This transaction reflects a private equity firm (GTCR) reducing its stake in a publicly traded healthcare services company (Sotera Health). Such secondary offerings are common as private equity sponsors monetize their investments over time, often after an initial public offering (IPO). The healthcare services sector continues to see active investment and divestment by institutional players.

Related Party Transactions

• The sale of 8,000,000 shares of Common Stock by GTCR XI Funds constitutes a related party transaction, as GTCR entities are 10% owners of Sotera Health Co. and have director representation.

Stakeholder Impact

• Shareholders: The sale by a major institutional investor could lead to increased trading volume and potentially influence short-term stock price movements. It also reduces the concentration of ownership by GTCR.
• GTCR Entities: Realized significant capital from the sale, providing liquidity for their funds and investors.

Key Dates

Recommendation

A Form 4 filing primarily reports an insider transaction and does not typically provide enough fundamental information to warrant a strong buy or sell recommendation on its own. While a large sale by a significant shareholder could be a minor negative signal, the fact that it was a pre-planned Rule 10b5-1 transaction by a private equity firm suggests a strategic divestment rather than a reaction to new negative information. Investors should 'hold' and monitor future company performance and additional disclosures for a more comprehensive investment decision.

Keywords

Sotera Health, SHC, GTCR, Secondary Offering, Insider Sale, Form 4, Beneficial Ownership, Private Equity Exit